SEC Comment Letter for Profound Medical (PROF) — May 15, 2026
Profound Medical Corp.
Date: May 15, 2026 · CIK: 0001628808 · Accession: 0000000000-26-004996
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295811
Letter
Re: Profound Medical Corp. Registration Statement on Form S-3 Filed May 12, 2026 File No. 333-295811 Dear Rashed Dewan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions.
May 15, 2026
Rashed Dewan Chief Financial Officer Profound Medical Corp. 2400 Skymark Avenue, Unit 6 Mississauga, Ontario Canada, L4W 5K5
Sincerely,
Division of
Corporation Finance
Office of
Industrial Applications and Services
cc: Jeffrey P. Schultz, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 15, 2026 Rashed Dewan Chief Financial Officer Profound Medical Corp. 2400 Skymark Avenue, Unit 6 Mississauga, Ontario Canada, L4W 5K5 Re: Profound Medical Corp. Registration Statement on Form S-3 Filed May 12, 2026 File No. 333-295811 Dear Rashed Dewan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Jeffrey P. Schultz, Esq. </TEXT> </DOCUMENT>